Objective measurement
Move from visual estimation to digital flow sensing with a clear, reproducible readout.
Medeclina is developing RESP O₂ — a digital platform for precise oxygen flow measurement, continuous data capture and the pathway toward connected, closed-loop oxygen therapy.
Conventional analogue flowmeters remain widely used because they are familiar and simple. But visual reading, calibration variability and low-flow imprecision can limit reliability precisely when titration matters most.
Move from visual estimation to digital flow sensing with a clear, reproducible readout.
Create a time-stamped record of oxygen delivery instead of relying only on a bedside snapshot.
Build the data layer needed for remote monitoring, multimodal sensing and future automated titration.
RESP O₂ is being designed as a modular system: digital mass-flow sensing at the oxygen source, connectivity to a dedicated hub and integration of respiratory and physiological signals.
Medeclina is progressing RESP O₂ through a translational MedTech pathway, with the current focus on engineering refinement, clinical validation and regulatory-ready development.
Need identified from real-world oxygen therapy and respiratory rehabilitation workflows.
Digital flowmeter prototype developed and evaluated under controlled bench conditions.
Clinical validation planning, sensing architecture refinement and implementation design.
Design controls, verification and validation, market access and scalable manufacturing.
Clinical validation · technology partnerships · investment · translational development